Abstract:In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. an enzyme found in most plant and animal cells that functions as an oxidative catalyst. It decomposes hydrogen peroxide into hydrogen and water. a series of enzymatic reactions in aerobic organisms involving oxidative metabolism of acetyl units and producing high-energy phosphate compounds, which serve as the main source of cellular energy. optically rotating to the right. The rotation of interest in chemistry is induced by a chiral molecule. The direction of rotation cannot be predicted from the R or S designation of the configuration at the stereocenter: in some cases the R isomer is dextrorotatory and the S isomer is levorotatory, whereas in other cases it is the other way around. an enzyme in the body that is a powerful scavenger of free radicals; it helps to prevent peroxidation of cell membranes by consuming free peroxide in the cell. optically rotating to the left. The levorotatory isomer of optically active compounds is the form usually found in nature. a by-product of lipid metabolism in the body. It is also found in many foods and can be present in high amounts in rancid food. an enzyme that catalyzes the decomposition of a superoxide into hydrogen peroxide and oxygen. a transgenic mouse strain that overexpresses a mutant form of human amyloid precursor protein with the Swedish mutation (APPSw), resulting in high Aβ levels in the brain. a dementia that is caused by disease of the blood vessels of the brain (cerebrovascular disease). It is the second most common form of dementia after AD.

Huperzine A As Potential Treatment Of Alzheimer'S Disease: An Assessment On Chemistry, Pharmacology, And Clinical Studies

O4‐04–06: Huperzine A for Alzheimer's Disease

P4-308: Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer's disease: A phase ii multicenter randomized controlled trial

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.

Huperzine A, A Potential Therapeutic Agent for Treatment of Alzheimer's Disease

Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis

Review on clinical application of huperzine A in China

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

[Clinical Efficacy and Safety of Huperzine Alpha in Treatment of Mild to Moderate Alzheimer Disease, a Placebo-Controlled, Double-Blind, Randomized Trial].

Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase

Meta-analysis of Efficacy and Safety of Huperzine A for Mild and Moderate Alzheimer Disease

Huperzine A for Mild Cognitive Impairment.

Neuroprotective Effects of Huperzine A: New Therapeutic Targets for Neurodegenerative Disease

Recent Advances in Approved, Withdrawn, Experimental and Investigational Drugs in Clinical Trials for Alzheimer’s disease

Natural Products As Sources of New Lead Compounds for the Treatment of Alzheimer&#8217;s Disease

Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

Huperzine A for Vascular Dementia.

Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer's disease